Navigation Links
Zeus Webinar: Bioabsorbable Polymers as Biomaterials
Date:8/22/2008

Anticipated to promote greater awareness and understanding in the field of bioabsorbable polymers, Zeus presents free webinar on August 28, 2008

ORANGEBURG, S.C., Aug. 22 /PRNewswire/ -- Zeus, Inc., a leader in polymer science, is pleased to announce it will be hosting an informative and cutting-edge bioabsorbables webinar entitled, "Bioabsorbable Polymers as Biomaterials." Presented by Dr. Bruce Anneaux and James Lindsey, the webinar will provide insight into the development of synthetic bioabsorbable and biodegradable polymers and the application of these materials in the medical device industry. To register or for more details about this free webinar and its presenters, visit "New Information" at http://www.zeusinc.com.

Commenting on the webinar, Dr. Bruce Anneaux, Corporate Manager, Research & Development, said, "Zeus is committed to exploring and advancing innovative concepts and the widespread application of bioabsorbable polymers into the medical industry has the potential to revolutionize this field. It is this potential that makes this webinar particularly relevant and significant."

The webinar will focus primarily on the commercially available synthetic bioabsorbable polyesters with an emphasis on copolymer design. Attendees will also gain valuable information related to the following sub-topics:

-- Bioabsorbable Polymer Applications

-- Bioabsorbable Polyester Design

-- Biodegradation

-- Processing

-- Sterilization

-- Packaging

"There has been steady growth in the area of biomaterials and this webinar will provide insight into many of these advances as it relates to the medical device industry," said James Lindsey, Research Engineer. "The webinar seeks to enhance participants' understanding of the science of bioabsorbable materials and promote greater awareness of the many possibilities that lie ahead."

About Zeus, Inc.:

Zeus, Inc. is headquartered in Orangeburg, SC, USA. Zeus is a world leader in the design and production of high-performance polymer tubing used in demanding applications, operating 10 facilities on seven campuses in North America, Europe, and Asia. Zeus products and services are preferred by companies in medial, automotive, electrical fluid handling and mechanical markets. For more information, visit http://www.zeusinc.com.

Contact:

Creative Media Group

Email: publicrelations@zeusinc.com

866.272.4710

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Zeus, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. The Lancet Publishes Results From Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
2. Researchers engineer new polymers to change their stiffness and strength when exposed to liquids
3. Copolymers block out new approaches to microelectronics at NIST
4. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
5. National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications
6. ULURU Inc. to Present at the 8th World Biomaterials Congress
7. Nanocopoeia Licenses New Polymer-Based Biomaterials Platform From the University of Western Ontario
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology:
(Date:6/21/2016)... VANCOUVER, British Columbia , June 21, 2016 ... been appointed to the new role of principal ... has been named the director of customer development. ... , NuData,s chief technical officer. The moves reflect ... development teams in response to high customer demand ...
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems ... seamlessly log work hours, for employers to make sure the right employees are actually ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
Breaking Biology News(10 mins):